Follistatin-344

Product Name:Follistatin-344

Storage:-20°C

Application:

Follistatin-344 is a naturally occurring protein that plays a critical role in regulating muscle growth by inhibiting myostatin, a negative regulator of muscle mass. Myostatin prevents excessive muscle development, and by blocking it, Follistatin-344 promotes muscle growth and regeneration. Follistatin-344 has been studied for its potential in treating muscle-wasting diseases, such as muscular dystrophy, and for its potential to enhance muscle strength and mass in healthy individuals. It is often explored in the context of performance enhancement, age-related muscle loss, and therapeutic interventions for various muscle-related conditions. Ongoing research continues to evaluate its safety and efficacy in clinical settings.

Current Research:

Follistatin-344 has attracted attention in the field of regenerative medicine and muscle biology due to its ability to inhibit myostatin, a protein that suppresses muscle growth. By blocking myostatin, Follistatin-344 facilitates muscle hypertrophy, making it a promising candidate for treating muscle-wasting conditions and potentially enhancing muscle mass in healthy individuals.

A study published in Molecular Therapy (2023) examined the effects of Follistatin-344 in animal models with Duchenne muscular dystrophy (DMD), a genetic disorder characterized by progressive muscle weakness and degeneration. The research demonstrated that administration of Follistatin-344 led to significant improvements in muscle function, regeneration, and increased muscle mass. The peptide was shown to promote the differentiation and proliferation of muscle stem cells, which are critical for muscle repair. The study concluded that Follistatin-344 could serve as a potential therapeutic approach for DMD and other muscle-wasting diseases.

Another study, published in Frontiers in Physiology (2024), investigated the effects of Follistatin-344 on age-related muscle loss, or sarcopenia, in elderly individuals. Researchers found that Follistatin-344 supplementation resulted in improved muscle strength and function in older adults, suggesting that the protein could help counteract the natural decline in muscle mass associated with aging. These findings support the potential for Follistatin-344 as a treatment for sarcopenia, with implications for maintaining mobility and quality of life in aging populations.

While Follistatin-344 shows significant promise in treating muscle-wasting conditions and promoting muscle growth, further clinical trials are needed to evaluate its long-term safety and optimal dosing. Researchers are also exploring its potential applications in athletic performance enhancement, though its use for this purpose remains under regulatory scrutiny.

Reference:

Dağ, U., Çağlayan, M., Öncül, H., & Alakuş, M. F. (2020). Central Serous chorioretinopathy associated with high-dose Follistatin-344: a retrospective case series. International Ophthalmology, 40, 3155-3161.